Breaking News

Trump nominates new CDC director

April 17, 2026
rose-b-avatar-teal
Disability in Health Care Reporting Fellow

Earth Day is next week, meaning it’s time for one of my favorite traditions: listening to the annual 24-hour livestream of a marsh in unceded W̱SÁNEĆ territory in British Columbia.

You’ll hear birds and frogs and insects — and an airplane or two. You can even add your own call to the wetland chorus.

OK, here's the news.

POLITICS

Trump nominates new CDC director

HHS

President Trump announced on social media his next pick to head the Centers for Disease Control and Prevention: former deputy Surgeon General Erica Schwartz. The former public health leader will fill a key role that has been occupied mostly on a part-time or interim basis during the second Trump administration.

Schwartz spent much of her career in health roles in the U.S. military before serving as deputy surgeon general during the first Trump administration and helping coordinate the government’s response to the Covid-19 pandemic.

It’s unclear whether Schwartz can muster sufficient support in the Senate to be confirmed, but her background as a physician with federal service experience will likely be popular among lawmakers. Trump also announced appointees to other positions at the CDC and FDA. Read more from STAT’s Helen Branswell and Chelsea Cirruzzo.


IMMIGRATION

The deadly consequences of ICE detention

People detained by Immigration and Customs Enforcement are dying at a record rate during President Trump’s second term, according to a new JAMA analysis of federal records from 2004 to 2026.

The report authors found that at least 272 people died in ICE custody during those 22 years, though they note that these numbers are often undercounted. The mortality rate in the latest fiscal year, which began Oct. 1, 2025 and ends Sept. 30, 2026, is higher than any other year in nearly two decades so far, exceeding even the spike seen during the coronavirus pandemic.

Perhaps most worrisome? Nearly half of these deaths in custody are attributed to “undetermined causes.”

If you’ve been paying attention to the news, this finding is not shocking. The recent increases in mortality happened in conjunction with major changes in 2025, including fewer oversight mechanisms, detention expansion, and delayed medical care.

There’s more details in the study, including how adopting medical standards during the Bush and Obama eras led to fewer deaths during the agency’s infancy. Check out the data analysis and accompanying editorial.


GLP-DONE

Should researchers ditch the GLP-1 hormone as a target for weight loss?

Do we need to target the GLP-1 hormone to achieve effective weight loss? Maybe not, say the scientists whose work spurred the development of powerful anti-obesity drugs like Eli Lilly’s Zepbound.

This group of researchers has created an experimental drug that activates receptors of other hormones that could — based on data from rodent and monkey studies — result in weight loss comparable to what patients experience on drugs that target GLP-1’s, with fewer side effects.

The peer-reviewed draft published this week still needs its provocative hypothesis to be replicated in humans, but the paper challenges some key tenets of the development of approved obesity products. Read more from STAT’s Elaine Chen to learn which well-known scientists are trying to upend the field they helped create. 



RESEARCH

A new way to help liver transplant patients avoid organ rejection

Researchers are trying to train the immune system to tolerate transplanted organs. A small, early-stage study published today shows promise in taking cells from living donors — people giving a portion of their livers — to teach recipients’ immune systems to accept the foreign organs as their own.

Immune tolerance has long been the holy grail in transplant medicine, as anti-rejection regimens for patients can be extensive and involve numerous side effects. In the Nature Communications study, 13 patients received an infusion of cells taken from their donors a week before their transplants. After a year, eight of them met criteria for withdrawing their immune-suppressing drugs, and four went completely off immunosuppression (although one had to resume taking the drugs).

What were the results after three years? STAT’s Elizabeth Cooney has the study’s full readout.


VACCINES

Tetanus tales, part two

Earlier this week, the CDC reported on more than 400 cases of tetanus in the U.S. from 2009 to 2023, most in un- or under-vaccinated people. On Thursday, the agency released another report on four tetanus cases among kids in 2024. None were vaccinated.

In two of the cases, parents brought the children for medical care after the accidents that likely led to them developing tetanus. When told their children should get preventive care, including a tetanus vaccine and immunoglobulin, both families declined. All four kids had to be hospitalized for between eight and 45 days; two needed inpatient rehabilitation care after their hospital stays. All received tetanus immunoglobulin and at least one dose of tetanus vaccine while in hospital, but only one child got the recommended series of three doses.

The report doesn't list in detail what these children went through while ill. But an account of a similar hospitalization in 2017 painted a gruesome picture of an agonizing illness — for the child, the family, and the health professionals who provided care. That child had to be sedated for weeks, because any noise or stimulation triggered bone wrenching spasms. — Helen Branswell 


FIRST OPINION

Don’t believe headlines saying that vaccine skepticism is widespread

That viral Politico poll that supposedly captured Americans’ cratering support for vaccines? Be skeptical, says David Higgins, a physician whose work focuses on vaccine delivery, health policy, and communication. Or at the very least read the fine print.

Politico’s write-up of the poll suggested that “nearly half” of U.S. adults think the science on vaccines remains up for debate, a sentiment echoed by many other outlets. But a deeper dive into the question that birthed this data point shows it obscures more than it clarifies about attitudes towards vaccines. The touted finding also runs up against many surveys in recent years that show an erosion in confidence but still robust support for vaccines.

“How this type of information is gathered and interpreted has significant consequences on people’s beliefs and attitudes … it may change what clinicians say in the exam room, the decisions policymakers and leaders make, and ultimately become a self-fulfilling prophecy,” said Higgins. Read more.


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

What we're reading

  • Kennedy focuses on affordability, combating fraud in Capitol Hill hearings, STAT  
  • HHS brings on an affordability czar, Axios 
  • The alcohol crisis quietly hitting high-stress, “high-status” workers, Vox
  • Utah measles outbreak tops 600 cases, now most active in the US, CIDRAP

Thanks for reading! 
Rose


Enjoying Morning Rounds? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2026, All Rights Reserved.

No comments